news
Latest News
Apr 10, 2025
Cagent Vascular Initiates Patient Enrollment in the Serranator® vs. POBA OCT Study at Columbia University Medical Center
Apr 3, 2025
Cagent Vascular and 3comma Medical Announce Strategic Partnership to Expand International Distribution of Serranator Product Family in EU and MENA Regions
Mar 4, 2025
Paul Wilson Appointed as Chief Commercial Officer to Drive Growth and Market Expansion
Feb 3, 2025
Cagent Vascular Announces Launch of New Product Serranator SL-PRO for CLTI and Pedal Disease
Jan 28, 2025
Cagent Vascular Initiates the Serranator® POINT FORCE Observational Registry
Nov 12, 2024
Serranator Webinar November 2024
Oct 3, 2024
It's Time for a New Standard of Care: Addressing PAD with Serration Technology
Jun 11, 2024
Innovation with Serration: Serranator featured in Endovascular Today
May 7, 2024
Cagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive Officer
Feb 20, 2024
Cagent Vascular Raises $30 Million Series C Financing
Jul 11, 2023
Cagent Vascular announces initial RECOIL Study results
Jun 7, 2023
Study finds Serranator serration balloon safe and effective in pedal arteries
/news/cagent-vascular-initiates-patient-enrollment-in-the-serranator-vs-poba-oct-study-at-columbia-university-medical-center/news/cagent-vascular-and-3comma-medical-announce-strategic-partnership-to-expand-international-distribution-of-serranator-product-family-in-eu-and-mena-regions/news/paul-wilson-appointed-as-chief-commercial-officer-to-drive-growth-and-market-expansion/news/cagent-vascular-announces-launch-of-new-product-serranator-sl-pro-for-clti-and-pedal-disease/news/cagent-vascular-initiates-the-serranator-point-force-observational-registry/news/serranator-webinar/news/its-time-for-a-new-standard-of-care-addressing-pad-with-serration-technology/news/innovation-with-serration-serranator-featured-in-endovascular-today/news/cagent-vascular-appoints-chairman-brian-walsh-to-expanded-role-as-chief-executive-officer/news/cagent-vascular-raises-30-million-series-c-financing/news/cagent-vascular-announces-initial-recoil-study-results/news/study-finds-serranator-serration-balloon-safe-and-effective-in-pedal-arteries/news/serranator-featured-in-cath-lab-digest/news/endovascular-today-using-serranator-in-challenging-clti-cases/news/superior-lumen-gain-greater-volumetric-blood-flow-using-serranator-a-sub-analysis-of-the-prelude-btk-study/news/cagent-vascular-announces/news/sectoral-asset-management/news/prelude-btk-study-results/news/limb-salvage-issue/news/endovascular-today/news/serranator-device/news/prelude-btk/news/chairman-of-the-board/news/ce-mark/news/cagent-vascular-completes-enrollment-of-prelude-study-using-serranator-device